[Toxicity and pharmacological properties of antineoplastic antibiotic 1719 from the class of diazo compounds].
D000284:Administration, Oral; D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D000903:Antibiotics, Antineoplastic; D001391:Azo Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002415:Cats; D004285:Dogs; D005260:Female; D005973:Glutamine / Q000037:antagonists & inhibitors*; D006321:Heart / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D051379:Mice; D009929:Organ Size; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000187:drug effects; D013950:Thymus Gland / Q000187:drug effects; D014508:Urea / Q000097:blood
D000903:Antibiotics, Antineoplastic; D001391:Azo Compounds; D001786:Blood Glucose; D005973:Glutamine; D014508:Urea; D001663:Bilirubin
Issledovanie toksichnosti i farmakologicheskikh svoĭstv protivoopukholevogo antibiotika 1719 iz gruppy diazosoedineniĭ.